Literature DB >> 6153233

Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.

J D Horowitz, W J Lang, L G Howes, M R Fennessy, N Christophidis, M J Rand, W J Louis.   

Abstract

The acute effects of a single capsule of each of two phenylpropanolamine-containing preparations were determined in a group of healthy young adults, by means of a double-blind comparison with matching placebo preparations. Supine diastolic blood-pressure rose to 100 mm Hg or more in 12 out of 37 subjects taking an anorectic preparation ('Trimolets'; 85 mg phenylpropanolamine per capsule) and in 4 out of 34 subjects taking a decongestant preparation ('Contac 500'; 50 mg phenylpropanolamine per capsule). 20 of the subjects taking trimolets reported adverse side effects. The frequency and extent of the hypertensive response to high-dose phenylpropranolamine-containing preparations suggest that clinical use of such preparations should be reviewed and that their availability without prescription may not be appropriate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153233     DOI: 10.1016/s0140-6736(80)90490-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies.

Authors:  S H Thomas; K L Clark; R Allen; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

2.  Cerebral infarction after excessive use of nasal decongestants.

Authors:  J Montalbán; L Ibañez; C Rodriguez; M Lopez; J Sumalla; A Codina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

3.  Treatment of seasonal and perennial rhinitis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

4.  The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial.

Authors:  A S Petrulis; T F Imperiale; T Speroff
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

5.  Decongestant-induced hypertensive crisis.

Authors:  S A Backlin
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

6.  Phenylpropanolamine and cerebral hemorrhage.

Authors:  J R McDowell; H J LeBlanc
Journal:  West J Med       Date:  1985-05

Review 7.  Fixed combination drug therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

8.  Intranasally administered phenylephrine and blood pressure.

Authors:  M G Myers; J J Iazzetta
Journal:  Can Med Assoc J       Date:  1982-09-01       Impact factor: 8.262

Review 9.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 10.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.